More than 850,000 people in the UK have dementia caused by Alzheimer’s disease - and this figure is set to rise, meaning almost all of us are likely to know someone affected by the condition. Despite this Alzheimer’s still seems to be a taboo subject, resulting in too many people feeling ashamed to face a diagnosis, living with the illness and feeling cut off from their community or losing their friendships; they face the condition alone.

However, this does not have to be the reality of living with Alzheimer’s disease, there is a vast amount of support available to those living with the condition and extensive research going on behind the scenes to find a cure. Currently there is a new large-scale international drug trial which could be of interest to those people diagnosed and which will soon be open to applications from people living in the North of England

The new disease-modifying therapy aims to slow the decline in people living with very mild to moderate Alzheimer’s. Previous phases in this drug trial have reported successfully halting the decline in memory, whilst noting positive therapeutic changes, including improved alertness, mood and engagement with family and friends. Researchers are now preparing to begin a larger trial of patients across the North of England. The trial will run for 12 months and there are no costs incurred to participants.

For more information about how to live as positively as possible with Alzheimer’s, or to find out how to register your interest in participating in this new trial, please contact us on 030 300 30003.